Joint association of plasma ceramide and renal function with coronary artery lesion severity: The CRUISE-MET study

Qiang Chen1, Yike Li1, Haoming He1

  • 1Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (Drs Chen, Li, He, Xie, Yang, Zhou, and Zheng); Department of Cardiology, China-Japan Friendship Hospital, Beijing, China (Drs Chen, Li, He, Xie, D. Fu, Gao, Li, S. Fu, Mu, Sun, Yang, Zhou, Li, Gao, and Zheng).

PubMed

Insights

Chronic kidney disease (CKD) and elevated ceramides, particularly Cer (18:1/16:0), synergistically increase the risk of complex coronary artery disease (CAD). This highlights the need for combined biomarker assessment and targeted therapies for atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biochemistry

Background:

  • Ceramides and chronic kidney disease (CKD) are known independent risk factors for atherosclerosis.
  • The synergistic impact of ceramides and CKD on coronary lesion severity is not well understood.

Purpose of the Study:

  • To investigate the combined effect of specific ceramide species and renal dysfunction on coronary lesion complexity in patients with coronary artery disease (CAD).

Main Methods:

  • Cross-sectional analysis of 691 CAD patients from the CRUISE-MET trial.
  • Quantification of six ceramide species using ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry.
  • Classification of complex CAD (bSS > 22) and CKD (based on eGFR and UACR).
  • Evaluation of combined and mediating effects of ceramides and renal dysfunction on coronary lesion complexity.

Main Results:

  • Patients with complex lesions had elevated UACR, specific ceramides (Cer (18:1/16:0), Cer (18:1/18:0), Cer (18:1/24:1)), and decreased eGFR.
  • Cer (18:1/16:0) showed the strongest correlation with baseline SYNTAX score (bSS) and highest predictive accuracy for complex CAD.
  • Combined CKD and elevated Cer (18:1/16:0) significantly increased complex CAD risk (OR = 4.40).
  • Renal impairment mediated a significant portion of ceramide's atherogenic effects.

Conclusions:

  • Ceramide-renal synergy exacerbates coronary atherosclerosis.
  • Integrated biomarker profiling of ceramides and renal function is recommended for risk stratification.
  • Dual-targeted therapies addressing both ceramides and renal dysfunction may be beneficial for managing atherosclerosis.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
395
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
329